funder-graph › Recipients
Who funds Global Alliance for Tb Drug Development Inc
EIN 13-4128413 · New York, NY · NTEE H80
Global Alliance for Tb Drug Development Inc of New York, NY (EIN 13-4128413) was named as a grant recipient by 6 funders in 24 grants paid totaling $103,896,516 in tax years 2017–2024, as reported on the funders' Forms 990-PF and 990 Schedule I. Each edge was resolved to this EIN at the match tier shown. Dataset version 2026.09.0, built 2026-09-03.
Grants received
$103,896,516
24 grants paid
Funders
6
distinct grantmakers
Tax years
2017–2024
as reported by funders
Approved for future payment
$14,950,000
not included in grants received
Funders
| Funder | State | Match | Grants | Total paid | Latest year |
|---|---|---|---|---|---|
| Bill & Melinda Gates Foundation 56-2618866 | WA | BC | 14 | $102,330,839 | 2024 |
| National Philanthropic Trust 23-7825575 | PA | A | 2 | $1,519,232 | 2021 |
| Grace Jones Richardson Testamentary Trust C/O Piedmont Trust Co 06-6023003 | NC | B | 3 | $30,000 | 2024 |
| Johns Hopkins University 52-0595110 | MD | A | 1 | $8,120 | 2018 |
| Vanguard Charitable Endowment Program 23-2888152 | PA | A | 1 | $8,000 | 2024 |
| Amazonsmile Foundation 46-2626883 | WA | B | 3 | $325 | 2023 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Grants
The 25 most recent grants naming this organization.
| Tax year | Funder | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|---|
| 2024 | Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $14,950,000 | paid | TUBERCULOSIS | 202523189349103667 |
| 2024 | Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $400,000 | paid | TUBERCULOSIS | 202523189349103667 |
| 2024 | Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $150,000 | paid | DEVELOPMENT OF SOLUTIONS TO IMPROVE GLOBAL HEALTH | 202523189349103667 |
| 2024 | Grace Jones Richardson Testamentary Trust C/O Piedmont Trust Co | Global Alliance for Tb Drug Development Inc New York, NY | B | $12,000 | paid | TO ASSIST THE ORGANIZATION IN CARRYING OUT ITS EXEMPT PURPOSE | 202523179349100327 |
| 2024 | Vanguard Charitable Endowment Program | Global Alliance for Tb Drug Development Inc New York City, NY | A | $8,000 | paid | FOR RECIPIENT'S EXEMPT PURPOSE | 202511349349313096 |
| 2023 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $14,950,000 | approved, future | TUBERCULOSIS | 202433189349102233 |
| 2023 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $14,950,000 | paid | TUBERCULOSIS | 202433189349102233 |
| 2023 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $1,782,950 | paid | TUBERCULOSIS | 202433189349102233 |
| 2023 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $10,000 | paid | RESEARCH AND LEARNING OPPORTUNITIES | 202433189349102233 |
| 2023 | Grace Jones Richardson Testamentary Trust C/O Piedmont Trust Co | Global Alliance for Tb Drug Development Inc New York, NY | B | $9,000 | paid | TO ASSIST THE ORGANIZATION IN CARRYING OUT ITS EXEMPT PURPOSE | 202413329349101211 |
| 2023 | Amazonsmile Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $81 | paid | GENERAL SUPPORT | 202540919349100629 |
| 2022 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $14,322,100 | paid | TUBERCULOSIS | 202303179349101020 |
| 2022 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $5,102,550 | paid | TUBERCULOSIS | 202303179349101020 |
| 2022 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $80,000 | paid | DEVELOPMENT OF SOLUTIONS TO IMPROVE GLOBAL HEALTH | 202303179349101020 |
| 2022 | Grace Jones Richardson Testamentary Trust C/O Piedmont Trust Co | Global Alliance for Tb Drug Development Inc New York, NY | B | $9,000 | paid | TO ASSIST THE ORGANIZATION IN CARRYING OUT ITS EXEMPT PURPOSE | 202303179349101225 |
| 2022 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $5,000 | paid | RESEARCH AND LEARNING OPPORTUNITIES | 202303179349101020 |
| 2022 | Amazonsmile Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $142 | paid | GENERAL SUPPORT | 202313119349100141 |
| 2021 | National Philanthropic Trust | Global Alliance for Tb Drug Development Inc New York, NY | A | $19,232 | paid | INTERNATIONAL | 202231339349309863 |
| 2020 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $21,140,000 | paid | TUBERCULOSIS | 202143159349100004 |
| 2020 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $5,000 | paid | RESEARCH AND LEARNING OPPORTUNITIES | 202143159349100004 |
| 2020 | Amazonsmile Foundation | Global Alliance for Tb Drug Development Inc New York, NY | B | $102 | paid | GENERAL SUPPORT | 202113199349100901 |
| 2018 | National Philanthropic Trust | Global Alliance for Tb Drug Development Inc New York, NY | A | $1,500,000 | paid | PUBLIC, SOCIETAL BENEFIT | 201921359349311817 |
| 2018 | Johns Hopkins University | Global Alliance for Tb Drug Development New York, NY | A | $8,120 | paid | SUB-AWARD | 201931349349307448 |
| 2017 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Dev New York, NY | C | $27,336,891 | paid | TUBERCULOSIS | 201941489349100174 |
| 2017 | Bill & Melinda Gates Foundation | Global Alliance for Tb Drug Dev New York, NY | C | $2,096,348 | paid | DEVELOPMENT OF SOLUTIONS TO IMPROVE GLOBAL HEALTH | 201941489349100174 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are inferred and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF and Form 990 Schedule I e-file XML filed by the funders shown; this organization's identity from the IRS Exempt Organizations Business Master File. Dataset version 2026.09.0, built 2026-09-03. The rows as Parquet: manifest.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.